About

Former journalist intern. Melanie has studied in Germany and Denmark and did an internship at Novo Nordisk, where she had a glimpse to the workings of pharma. She is now a Ph.D. student at the IMP in Vienna.

Articles by Melanie De Almeida

German Biotech Unveils Positive Phase II Results for Alzheimer’s

French Biotech Strikes Deal with Novo Nordisk for New Cancer Drug

Startup Scout 2 Jun 2017

This French Biotech Wants to Reinvent DC-based Immunotherapies

German Biotech Enters the Clinic with Next-Generation Antibody for AML

Swiss Researchers get to the Genetic Bottom of Kidney Cancer

More News! 30 May 2017

FDA Fast Tracks Muscular Dystrophy Drug backed by Woodford

ADVERTISEMENT
Interview 25 May 2017

How Biotech Will Make Us Live Longer – Let’s Talk Anti-Aging

Interview 25 May 2017

Cross-Innovation in Healthcare – Discussing Trends and Challenges

French Biotech Enters New Agreement to Advance its IBD Immunotherapy

German Biotech Tops Up its Oncolytic Virus with Immuno-Oncology Drugs

Norwegian Biotech Goes for Combination Therapies in Melanoma

Spanish Biotech Clears €2.7M Funding Round for its New Stroke Drug

ADVERTISEMENT